Non-Alcoholic Fatty Liver Disease (NAFLD) is a rapidly growing health concern affecting an estimated 38% of the global population. Dr. Gyanranjan Rout, a Consultant-Medical Gastroenterologist, highlights the rise of NAFLD due to obesity, diabetes, and sedentary lifestyles. The disease is often asymptomatic but can progress to severe conditions such as NASH, cirrhosis, or liver cancer if left untreated.
Currently, there are no specific drugs approved for treating NAFLD, but lifestyle changes such as weight loss through a healthy diet and exercise are recommended. Controlling comorbid conditions like type 2 diabetes is also important. Some treatments like Saroglitazar and vitamin E have shown positive results in NASH patients, while new therapies like obeticholic acid are being studied.
Dr. Rout emphasizes the importance of early diagnosis and proactive measures in preventing and managing NAFLD. While there is no one-size-fits-all treatment, a combination of lifestyle interventions, medical treatments, and ongoing research provides hope for improved outcomes. This article serves as a reminder to seek professional medical advice for any concerns related to NAFLD. Readers are encouraged to stay informed and proactive about their health to reduce the risk of developing this increasingly common liver disease.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
